Metastatic breast cancer trials in Colombia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  Where

  Bogotá, Medellín, Montería, Valledupar

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07060807 · EU 2025-520582-51-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  Where

  Barranquilla, Bogota, D.C., Montería, Valledupar

  Age

  18 years and over

  People

  230 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT05894239 · EU 2022-502046-28-00
• Phase 3Taking people
  A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  Where

  Bogotá, Cali, Medellín, Montería, Valledupar

  Age

  18 years and over

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06312176 · EU 2023-504918-29-00